Current through the 2024 legislative session
Section 35-4-903 - Prescription of epinephrine auto-injector or opiate antagonist(a) A practitioner or a pharmacist acting in good faith and exercising reasonable care may, without a prescriber-patient relationship, prescribe an epinephrine auto-injector or an opiate antagonist to:(i) A person at risk of experiencing anaphylaxis or an opiate related drug overdose;(ii) A person in a position to assist a person at risk of experiencing anaphylaxis or an opiate related drug overdose;(iii) A person who, in the course of the person's official duties or business, may encounter a person experiencing anaphylaxis or an opiate related drug overdose.(b) A practitioner or pharmacist who prescribes an epinephrine auto-injector or an opiate antagonist under this article shall provide education to the person to whom the epinephrine auto-injector or opiate antagonist is prescribed, which shall include written instruction on how to: (i) Recognize anaphylaxis or an opiate related drug overdose;(ii) Respond appropriately to an anaphylaxis or opiate related drug overdose event, including how to administer epinephrine through use of an epinephrine auto-injector or administer an opiate antagonist;(iii) Ensure that a person to whom epinephrine or an opiate antagonist has been administered receives, as soon as possible, additional medical care and a medical evaluation.Amended by Laws 2022 , ch. 69, § 1, eff. 7/1/2022.Added by Laws 2017 , ch. 136, § 1, eff. 7/1/2017.